CCOC(=O)c1c(N/C=C2\C(=O)NC(=S)N(c3ccc(F)cc3)C2=O)sc2c1CCCC2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?